Administrative Information

Current Board Members

Immediate Past Board Members

*Due to changes in REB membership, past lists are available. Please contact ethics@uwo.ca for any past lists you may require.

Ontario Cancer Research Ethics Board (OCREB) Protocols

Â鶹´«Ã½ and Lawson Research Institute (Lawson)/London Health Sciences Centre Research Institute (LHSCRI) are committed to ensuring  cancer patients attending London's hospitals have the opportunity to participate in multi-centred, time-sensitive, competitive enrollment cancer clinical trials. In an effort to facilitate this process, Â鶹´«Ã½ and Lawson/LHSCRI have agreed to sanction the use of the Ontario Cancer Research Ethics Board (OCREB) in lieu of Â鶹´«Ã½’s Health Sciences Research Ethics Board (HSREB).

Conditions:

  • Acceptance of OCREB as an alternate research ethics board is limited to the ethical review of new multi-centre cancer clinical trials where the study sponsor has identified OCREB as the preferred research ethics board provincially; and, where Â鶹´«Ã½ and/or Lawson/LHSCRI investigators are leading and/or participating in these trials. All other types of research previously approved by OCREB must still obtain approval from Â鶹´«Ã½’s HSREB (e.g., epidemiological, tissue use, non-clinical).
  • Ongoing cancer clinical trials currently under review by, or approved by, Â鶹´«Ã½’s HSREB will remain under the jurisdiction of Â鶹´«Ã½’s HSREB until completion of the trial.
  • Â鶹´«Ã½ and Lawson/LHSCRI retain the right to require ethical approval from Â鶹´«Ã½’s HSREB for studies previously approved by OCREB if, in their opinion, circumstances warrant it.
  • Â鶹´«Ã½’s HSREB accepts no responsibility for the conduct of research conducted under the auspices of OCREB, for which Â鶹´«Ã½’s HSREB has not issued an approval notice.

Further reading: OCREB Guidelines